|
 |
Huntingtons Disease > LAX-101
The following information is about LAX-101.
LAX-101 Defined
A purified form of eicopentaenoic acid (EPA) that has shown some efficacy in slowing the progression of HD in a phase III clinical trial.
This definition is in context to Huntingtons Disease. See more contextual defintions for LAX-101.
Are you looking for additional Huntingtons Disease > Lax-101 news? Try our new "Lax-101 News Focus" area.
Social bookmarks are not available at the moment.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > LAX-101. If you would like to find related tags we recommend Tag Patterns > LAX-101
Off-site Lax-101 Research Links
If you still need additional information on Lax-101 then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Huntingtons Disease Topics
Everything you need to know about Huntingtons Disease
Huntingtons Disease
If you know the Huntingtons Disease Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Huntingtons-Disease.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.